Inequivocal data proving DCB safety in AVF - insights from Dr Mallios

Dr Mallios shares his view on the first and only consistently positive randomised controlled trial results that are “unequivocally” in favor of drug-coated balloon (DCB) therapy for AV fistula patients.​
The latest 5-year data from the IN.PACTᵀᴹ AV Access Trial confirms the safety of DCB in this patient population. The trial also reinforces the positive impact of DCB on their quality of life by reducing the number of interventions needed for treatment.